Financhill
Buy
76

DXPE Quote, Financials, Valuation and Earnings

Last price:
$114.96
Seasonality move :
25.26%
Day range:
$111.91 - $115.98
52-week range:
$67.68 - $130.97
Dividend yield:
0%
P/E ratio:
21.81x
P/S ratio:
0.97x
P/B ratio:
3.69x
Volume:
51K
Avg. volume:
194.2K
1-year change:
40.78%
Market cap:
$1.8B
Revenue:
$1.8B
EPS (TTM):
$5.27

Earnings Data

Next earnings date for DXPE
Mar 05
2026
Most recent earnings per share
$1.31
Missed by $0.26
(Nov 6/2025)
Consensus Estimate
$1.57
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

DXPE Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/05/2026 Q4 $499M -- -- $1.30 --
11/06/2025 Q3 $498.8M $513.7M $1.31 $1.57 -$0.26
08/06/2025 Q2 $499M $498.7M $1.43 $1.39 $0.04
05/08/2025 Q1 $477M $476.6M $1.25 $1.20 $0.05
03/06/2025 Q4 $447M $470.9M $1.29 $0.89 $0.40
11/04/2024 Q3 $443M $472.9M $1.27 $0.95 $0.32
08/08/2024 Q2 $434M $445.6M $1.00 $0.80 $0.20
05/08/2024 Q1 $412M $412.6M $0.67 $0.71 -$0.04
03/07/2024 Q4 $411M $407M $0.94 $0.36 $0.58
11/09/2023 Q3 -- $419.2M $0.93 -- --
08/08/2023 Q2 -- $428M $1.05 -- --
05/11/2023 Q1 -- $424.3M $0.95 -- --
03/24/2023 Q4 -- $406.3M $0.37 -- --
11/09/2022 Q3 -- $387.3M $0.71 -- --
08/08/2022 Q2 -- $367.8M $0.74 -- --
05/10/2022 Q1 -- $319.4M $0.65 -- --
03/25/2022 Q4 -- $293.1M $0.04 -- --
12/08/2021 Q3 -- $289.5M $0.36 -- --
08/06/2021 Q2 -- $285.7M $0.40 -- --
05/07/2021 Q1 -- $245.6M $0.02 -- --
03/09/2021 Q4 -- $232.7M -$0.13 -- --
11/06/2020 Q3 -- $220.2M -$1.95 -- --
08/06/2020 Q2 -- $251.4M $0.13 -- --
05/08/2020 Q1 -- $301M $0.33 -- --
03/06/2020 Q4 -- $293.1M $0.18 -- --
11/06/2019 Q3 -- $327.2M $0.71 -- --
08/06/2019 Q2 -- $333.3M $0.73 -- --
05/07/2019 Q1 -- $311.2M $0.39 -- --
03/07/2019 Q4 -- $311M $0.60 -- --
11/05/2018 Q3 -- $308M $0.46 -- --
08/07/2018 Q2 -- $311.2M $0.63 -- --
05/08/2018 Q1 -- $285.9M $0.24 -- --
03/20/2018 Q4 -- $265.6M $0.36 -- --
11/02/2017 Q3 -- $251.9M $0.16 -- --
07/25/2017 Q2 -- $250.7M $0.23 -- --
03/31/2017 Q1 -- $238.5M $0.17 -- --
03/31/2017 Q4 -- $222.3M $0.42 -- --
11/07/2016 Q3 -- $230M $0.02 -- --
08/09/2016 Q2 -- $256.2M $0.34 -- --
05/13/2016 Q1 -- $253.6M -$0.35 -- --
02/26/2016 Q4 -- $278.7M -$0.20 -- --

DXP Enterprises, Inc. Earnings Questions

  • How Much did DXP Enterprises, Inc. Generate in Revenue Last Quarter?

    DXP Enterprises, Inc. reported $513.7M worth of top line sales in its most recent quarter.

  • Did DXP Enterprises, Inc. Beat Earnings Last Quarter?

    DXP Enterprises, Inc. announced earnings per share of $1.31 which represents a miss of analyst forecast a $1.57 per share.

  • Is DXP Enterprises, Inc. Profitable?

    DXP Enterprises, Inc. reported $161.3M that represents $9.76 per share over the last quarter.

  • What is the Analyst Consensus for DXP Enterprises, Inc. EPS Next Year?

    DXP Enterprises, Inc.'s earnings are forecast to grow from $4.22 per share to $4.07 per share next year representing an increase of 26.44%.

  • When is DXP Enterprises, Inc.'s Earnings Date?

    DXP Enterprises, Inc.'s next earnings date is March 5, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
85
HUT alert for Dec 25

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
63
GPCR alert for Dec 25

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock